Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Cannabinoid receptor activation reverses kainate-induced synchronized population burst firing in rat hippocampus.

Mason R, Cheer JF.

Front Integr Neurosci. 2009 Jun 15;3:13. doi: 10.3389/neuro.07.013.2009. eCollection 2009.

2.

Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors.

Cheer JF, Cadogan AK, Marsden CA, Fone KC, Kendall DA.

Neuropharmacology. 1999 Apr;38(4):533-41.

PMID:
10221757
3.

Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.

Lake KD, Compton DR, Varga K, Martin BR, Kunos G.

J Pharmacol Exp Ther. 1997 Jun;281(3):1030-7.

4.

The effect of co-administration of the NMDA blocker with agonist and antagonist of CB1-receptor on penicillin-induced epileptiform activity in rats.

Cakil D, Yildirim M, Ayyildiz M, Agar E.

Epilepsy Res. 2011 Feb;93(2-3):128-37. doi: 10.1016/j.eplepsyres.2010.11.008. Epub 2010 Dec 21.

PMID:
21177076
5.

Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions.

Pistis M, Perra S, Pillolla G, Melis M, Gessa GL, Muntoni AL.

Neuropharmacology. 2004 Jan;46(1):115-25.

PMID:
14654103
6.

Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum.

Cheer JF, Kendall DA, Mason R, Marsden CA.

Neuropharmacology. 2003 Apr;44(5):633-41.

PMID:
12668049
7.

Effect of the CB(1) receptor antagonists rimonabant and AM251 on the firing rate of dorsal raphe nucleus neurons in rat brain slices.

Mendiguren A, Pineda J.

Br J Pharmacol. 2009 Nov;158(6):1579-87. doi: 10.1111/j.1476-5381.2009.00434.x. Epub 2009 Oct 20.

8.

Inhibition of endocannabinoid metabolism attenuates enhanced hippocampal neuronal activity induced by kainic acid.

Coomber B, O'Donoghue MF, Mason R.

Synapse. 2008 Oct;62(10):746-55. doi: 10.1002/syn.20547.

PMID:
18651640
9.

The effects of intracerebroventricular AM-251, a CB1-receptor antagonist, and ACEA, a CB1-receptor agonist, on penicillin-induced epileptiform activity in rats.

Kozan R, Ayyildiz M, Agar E.

Epilepsia. 2009 Jul;50(7):1760-7. doi: 10.1111/j.1528-1167.2009.02098.x. Epub 2009 Apr 27.

10.

Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects.

Wallace MJ, Wiley JL, Martin BR, DeLorenzo RJ.

Eur J Pharmacol. 2001 Sep 28;428(1):51-7.

PMID:
11779037
11.

The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy.

Wallace MJ, Blair RE, Falenski KW, Martin BR, DeLorenzo RJ.

J Pharmacol Exp Ther. 2003 Oct;307(1):129-37. Epub 2003 Sep 3.

12.

Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation.

Darmani NA, Sim-Selley LJ, Martin BR, Janoyan JJ, Crim JL, Parekh B, Breivogel CS.

Eur J Pharmacol. 2003 Jan 10;459(1):83-95.

PMID:
12505537
13.

Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons.

Liu Q, Bhat M, Bowen WD, Cheng J.

J Pharmacol Exp Ther. 2009 Dec;331(3):1062-70. doi: 10.1124/jpet.109.156216. Epub 2009 Sep 14.

14.

Changes in the cannabinoid (CB1) receptor expression level and G-protein activation in kainic acid induced seizures.

Bojnik E, Turunç E, Armağan G, Kanıt L, Benyhe S, Yalçın A, Borsodi A.

Epilepsy Res. 2012 Mar;99(1-2):64-8. doi: 10.1016/j.eplepsyres.2011.10.020. Epub 2011 Nov 10.

PMID:
22079489
15.
16.

Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices.

Ameri A, Simmet T.

Naunyn Schmiedebergs Arch Pharmacol. 2000 Mar;361(3):265-72.

PMID:
10731038
17.

Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.

Craft RM, Wakley AA, Tsutsui KT, Laggart JD.

J Pharmacol Exp Ther. 2012 Mar;340(3):787-800. doi: 10.1124/jpet.111.188540. Epub 2011 Dec 19.

18.

The synthetic cannabinoid HU210 induces spatial memory deficits and suppresses hippocampal firing rate in rats.

Robinson L, Goonawardena AV, Pertwee RG, Hampson RE, Riedel G.

Br J Pharmacol. 2007 Jul;151(5):688-700. Epub 2007 May 14.

19.

Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum.

Szabo B, Dörner L, Pfreundtner C, Nörenberg W, Starke K.

Neuroscience. 1998 Jul;85(2):395-403.

PMID:
9622239
20.

Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats.

Cheer JF, Wassum KM, Heien ML, Phillips PE, Wightman RM.

J Neurosci. 2004 May 5;24(18):4393-400.

Items per page

Supplemental Content

Write to the Help Desk